1. Home
  2. AXNX vs DV Comparison

AXNX vs DV Comparison

Compare AXNX & DV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXNX
  • DV
  • Stock Information
  • Founded
  • AXNX 2012
  • DV 2008
  • Country
  • AXNX United States
  • DV United States
  • Employees
  • AXNX N/A
  • DV N/A
  • Industry
  • AXNX Medical/Dental Instruments
  • DV Computer Software: Prepackaged Software
  • Sector
  • AXNX Health Care
  • DV Technology
  • Exchange
  • AXNX Nasdaq
  • DV Nasdaq
  • Market Cap
  • AXNX 3.5B
  • DV 3.0B
  • IPO Year
  • AXNX N/A
  • DV 2021
  • Fundamental
  • Price
  • AXNX $69.63
  • DV $17.25
  • Analyst Decision
  • AXNX Hold
  • DV Buy
  • Analyst Count
  • AXNX 9
  • DV 17
  • Target Price
  • AXNX $70.67
  • DV $31.69
  • AVG Volume (30 Days)
  • AXNX 340.6K
  • DV 2.8M
  • Earning Date
  • AXNX 10-28-2024
  • DV 11-07-2024
  • Dividend Yield
  • AXNX N/A
  • DV N/A
  • EPS Growth
  • AXNX N/A
  • DV 9.13
  • EPS
  • AXNX N/A
  • DV 0.34
  • Revenue
  • AXNX $408,809,000.00
  • DV $612,877,000.00
  • Revenue This Year
  • AXNX $25.48
  • DV $20.72
  • Revenue Next Year
  • AXNX $19.56
  • DV $18.22
  • P/E Ratio
  • AXNX N/A
  • DV $50.69
  • Revenue Growth
  • AXNX 27.81
  • DV 22.03
  • 52 Week Low
  • AXNX $48.30
  • DV $16.53
  • 52 Week High
  • AXNX $69.91
  • DV $43.00
  • Technical
  • Relative Strength Index (RSI)
  • AXNX 62.61
  • DV 43.85
  • Support Level
  • AXNX $69.10
  • DV $16.53
  • Resistance Level
  • AXNX $69.67
  • DV $17.49
  • Average True Range (ATR)
  • AXNX 0.34
  • DV 0.47
  • MACD
  • AXNX 0.03
  • DV 0.04
  • Stochastic Oscillator
  • AXNX 82.50
  • DV 53.93

About AXNX Axonics Inc.

Axonics Inc is a United States-based medical technology company. It focuses on developing and commercializing novel products for adults with bladder and bowel dysfunction, that include implantable SNM systems to treat urinary urge incontinence and urinary urgency frequency (UUF); a urethral bulking agent (Bulkamid) to treat female stress urinary incontinence. SNM therapy is predominantly used to treat patients with overactive bladder, fecal incontinence, and urinary retention. Geographically, the company generates majority of its revenue from United States and rest from International markets.

About DV DoubleVerify Holdings Inc.

DoubleVerify Holdings Inc is a digital media measurement and analytics software platform. The DV Authentic Ad ensures that a digital ad was delivered in a brand-safe setting, completely viewable, by a real individual, and in the expected geography, is one of its solutions. It generates revenues from its advertisement customers by charging a Measured Transaction Fee on the volume of Media Transactions Measured on the software platform.

Share on Social Networks: